Gossamer Bio, Inc.
GOSS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728117
No open-market purchases or sales by Gossamer Bio, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Gossamer Bio, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 129 | 160 | +31 |
| Shares | 63.7M | 85.2M | +21.5M (+33.8%) |
| Value | $533.2M | $1.02B | +$487.6M (+91.4%) |
New holders (44)
Institutions that held Gossamer Bio, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (13)
Institutions that held Gossamer Bio, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Point72 Asset Management, L.P. | 963,400 | $8.06M |
| Walleye Capital LLC | 557,366 | $4.67M |
| Norges Bank | 309,300 | $2.59M |
| Alyeska Investment Group, L.P. | 114,608 | $959.0K |
| Cinctive Capital Management LP | 103,519 | $866.0K |
| Martingale Asset Management L P | 50,027 | $420.0K |
| Trexquant Investment LP | 20,378 | $171.0K |
| Delphia (USA) Inc. | 11,935 | $100.0K |
| Corton Capital Inc. | 10,912 | $91.0K |
| Captrust Financial Advisors | 390 | $3.00K |
| Laurel Wealth Advisors LLC | 200 | $2.00K |
| Howe & Rusling Inc | 100 | $1.00K |
| Venture Visionary Partners LLC | 100 | $837 |